| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Bristol-Myers Squibb (NYSE:BMY) is gearing up to announce its quarterly earnings on Thursday, 2025-10-30. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Bristol-Myers Squibb will report an earnings per share (EPS) of $1.51.
The market awaits Bristol-Myers Squibb's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
The company's EPS beat by $0.31 in the last quarter, leading to a 2.12% increase in the share price on the following day.
Here's a look at Bristol-Myers Squibb's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | 1.15 | 1.49 | 1.47 | 1.49 |
| EPS Actual | 1.46 | 1.80 | 1.67 | 1.80 |
| Price Change % | 2.00 | -2.00 | -1.00 | -3.00 |
Shares of Bristol-Myers Squibb were trading at $42.82 as of October 28. Over the last 52-week period, shares are down 23.2%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
To track all earnings releases for Bristol-Myers Squibb visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: BMY
